"Well done is better than well said"
Benjamin Franklin
Cancer Immunotherapy
CAR T Cells
CAR T cell therapy has demonstrated remarkable success, especially in certain blood cancers, such as acute lymphoblastic leukemia (ALL) and certain types of lymphomas. It has shown impressive results in patients who have not responded to standard treatments or have relapsed after previous therapies.
TCR-modified T Cells
TCR-modified T-cell therapy represents a promising and innovative frontier in cancer treatment, empowering the body's immune system to combat cancer in a targeted manner. As research progresses and technology advances, this approach holds great potential to transform cancer therapy and improve outcomes for patients facing challenging cancer types.
Immune Checkpoint Blockade
The immune system has built-in "checkpoints" that regulate its activity and prevent it from attacking healthy cells in the body. These checkpoints serve as control mechanisms to maintain immune balance and prevent excessive immune activation. Checkpoint blockade therapy has shown remarkable success in various cancer types, leading to long-lasting responses in some patients. It has become a significant advancement in cancer treatment.
